Literature DB >> 16301324

Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.

Arturo Jiménez-Periañez1, Gloria Ojeda, Gabriel Criado, Alejandra Sánchez, Eliana Pini, Joaquín Madrenas, Jose Maria Rojo, Pilar Portolés.   

Abstract

Crry/p65 is a type I glycoprotein, which protects mouse T cells from complement attack. We have previously shown that complement receptor I-related protein Crry/p65 (Crry) ligation has a costimulatory effect on mouse CD4+ T cell activation. Here, we have examined the mechanisms responsible for Crry costimulation, addressing the question of whether Crry potentiates signal transduction starting at the T cell receptor (TCR)/CD3 complex or promotes distinct costimulatory signals. We show that Crry increases early TCR-dependent activation signals, including p56lck-, zeta-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. A fraction of Crry is found consistently in the detergent-insoluble membrane fraction of Th1 or Th2 cells or CD4+ lymphoblasts. Crry costimulation induced clustering of lipid rafts, increasing their content in Crry, CD3epsilon, and p59-60 forms of p56lck, and caused actin polymerization close to the site of activation in Th2 cells. Such events were inhibited by wortmannin, suggesting a role for phosphatidylinositol-3 kinase in these effects. The Crry cytoplasmic domain was required for JNK activation and interleukin-4 secretion but not for the presence of Crry in rafts or activation of p56lck, ZAP-70, Akt, Vav-1, or ERK. This suggests that Crry costimulation involves two different but not mutually exclusive signal transduction modules. The dual function of Crry as a complement regulatory protein and as a T cell costimulator illustrates the importance of complement regulatory proteins as links between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301324     DOI: 10.1189/jlb.1104642

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  C3-dependent mechanism of microglial priming relevant to multiple sclerosis.

Authors:  Valeria Ramaglia; Timothy R Hughes; Rossen M Donev; Marieta M Ruseva; Xiaobo Wu; Inge Huitinga; Frank Baas; James W Neal; B Paul Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

Review 2.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

3.  Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.

Authors:  Qing Li; Danping Huang; Kristine Nacion; Hong Bu; Feng Lin
Journal:  Mol Immunol       Date:  2009-08-05       Impact factor: 4.407

4.  An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.

Authors:  Svetlana N Tchepeleva; Joshua M Thurman; Katherine Ruff; Stephen J Perkins; Laurence Morel; Susan A Boackle
Journal:  J Immunol       Date:  2010-07-21       Impact factor: 5.422

Review 5.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

6.  Abnormal Tr1 differentiation in multiple sclerosis.

Authors:  Anne L Astier; David A Hafler
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

7.  Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis.

Authors:  Jindrich Soltys; Xiaobo Wu
Journal:  J Inflamm (Lond)       Date:  2012-05-29       Impact factor: 4.981

8.  Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury.

Authors:  Mou Gao; Qin Dong; Wenjia Wang; Zhijun Yang; Lili Guo; Yingzhou Lu; Boyun Ding; Lihua Chen; Jianning Zhang; Ruxiang Xu
Journal:  Stem Cell Res Ther       Date:  2021-02-12       Impact factor: 6.832

9.  Crry silencing alleviates Alzheimer's disease injury by regulating neuroinflammatory cytokines and the complement system.

Authors:  Xi-Chen Zhu; Lu Liu; Wen-Zhuo Dai; Tao Ma
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.